NR4A3 and graft versus host disease: Although major histocompatibility complex (MHC)-matched transplantation significantly reduces the risk of GVHD, disparity at minor histocompatibility antigens (MiHA) continues to incur risk for GVHD whose target organs include intestine, skin, and liver (5–7).